{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-040614","form_type":"8-K","ticker":"NXGL","cik":"0001468929","company_name":"NEXGEL, INC.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.159140+00:00","generated_at":"2026-06-08T04:55:59.537337+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NEXGEL Q3: record revenue $1.2M (+115% YoY), net loss -$550K, gross margin 28.2%","bullets":["Revenue $1.2M, up 115% YoY from $568K; growth in contract manufacturing and branded products.","Gross profit margin 28.2% vs 26.1% YoY, sequentially improved from 15% in Q2 2023.","Net loss -$550K ($0.10/sh) vs -$1.2M ($0.22/sh) in Q3 2022; improved from -$642K in Q2 2023.","Operating expenses fell to $956K from $1.185M YoY; cash $3.3M as of Sep 30, 2023.","New supply agreement with AbbVie (ABBV) for gel pads; Enigma Health retail partnership announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-040614","json":"https://secwatch.observer/filing/0001493152-23-040614.json","markdown":"https://secwatch.observer/filing/0001493152-23-040614.md","text":"https://secwatch.observer/filing/0001493152-23-040614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468929/000149315223040614/0001493152-23-040614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468929/000149315223040614/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:55:59.537337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91a7582ed106e755fdd8ed53a9bf946bddf83832","claim":"NEXGEL, INC. reported third quarter ended September 30, 2023 results: revenue $1.2 million, EPS $0.10 per basic and diluted share.","evidence_excerpt":"shall be expressly set forth by specific reference in such a filing. --- EX-99.1 () --- EX-99.1 2 ex99-1.htm Exhibit 99.1 NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year Gross profit margin improved sequentially to 28.2% in Q3 as compared to 15.0% in Q2 LANGHORNE, Pa. – November 13, 2023 – NEXGEL, Inc.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315223040614/0001493152-23-040614-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$1.2 million"},{"label":"EPS","value":"$0.10 per basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}